USPTO serial 77678163
ELAQUIS
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- PERKINS, ELLEN J
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ELAQUIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Marilyn F. Kelly
Marilyn F. Kelly Bristol-Myers Squibb Company345 Park AvenueTrademark DepartmentNew York, NY 10154Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction and pain; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Pfizer Inc.
- Other trademarks owned by Pfizer Inc.
- Other trademarks owned by BRISTOL-MYERS SQUIBB COMPANY
- Other trademarks in Class 005
- Similar marks named ELAQUIS
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 24, 2011 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 24, 2011 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 30, 2011 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 30, 2011 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 1, 2011 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Mar 8, 2011 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 7, 2011 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Mar 1, 2011 | EXT3 | SOU EXTENSION 3 FILED | — |
| Mar 1, 2011 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 28, 2010 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 27, 2010 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Sep 21, 2010 | EXT2 | SOU EXTENSION 2 FILED | — |
| Sep 21, 2010 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 10, 2010 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 15, 2010 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 14, 2010 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 13, 2010 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 19, 2010 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 19, 2010 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 22, 2009 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 30, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 10, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| May 27, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 26, 2009 | ALIE | ASSIGNED TO LIE | — |
| May 26, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 13, 2009 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 13, 2009 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 13, 2009 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 13, 2009 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 11, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 2, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 28, 2009 | NWAP | NEW APPLICATION ENTERED | — |